QUINTO, ILEANA
 Distribuzione geografica
Continente #
NA - Nord America 2.769
AS - Asia 1.905
EU - Europa 1.008
SA - Sud America 369
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 6.084
Nazione #
US - Stati Uniti d'America 2.645
SG - Singapore 939
IT - Italia 471
CN - Cina 455
BR - Brasile 297
IN - India 179
VN - Vietnam 173
DE - Germania 146
SE - Svezia 135
GB - Regno Unito 99
CA - Canada 92
FI - Finlandia 54
KR - Corea 46
MX - Messico 24
AR - Argentina 23
HK - Hong Kong 20
EC - Ecuador 17
FR - Francia 17
JP - Giappone 17
BD - Bangladesh 16
NL - Olanda 14
ZA - Sudafrica 14
ID - Indonesia 13
UA - Ucraina 12
RU - Federazione Russa 10
PE - Perù 9
ES - Italia 8
PL - Polonia 8
CL - Cile 7
CZ - Repubblica Ceca 7
IL - Israele 7
PT - Portogallo 5
RO - Romania 5
SA - Arabia Saudita 5
VE - Venezuela 5
CO - Colombia 4
IQ - Iraq 4
IR - Iran 4
PY - Paraguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EU - Europa 3
GR - Grecia 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PK - Pakistan 3
TH - Thailandia 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
BB - Barbados 2
CH - Svizzera 2
EE - Estonia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
TN - Tunisia 2
UY - Uruguay 2
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
PH - Filippine 1
RS - Serbia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 6.084
Città #
Dallas 426
Chandler 396
Singapore 342
Santa Clara 159
Bengaluru 141
Hefei 141
Milan 139
Lawrence 135
Princeton 135
Munich 114
Ashburn 99
Catanzaro 75
Wilmington 75
London 68
Ottawa 67
Beijing 66
Ho Chi Minh City 66
Turku 49
Chicago 48
Des Moines 46
Boardman 40
Seattle 39
Hanoi 34
Los Angeles 29
Shanghai 24
Napoli 20
São Paulo 20
Hong Kong 19
Guangzhou 18
New York 17
Brooklyn 16
Naples 15
San Francisco 14
Augusta 13
Gwangjin-gu 13
Redmond 13
The Dalles 13
Columbus 12
Shenzhen 11
Taranto 11
Montreal 10
Seoul 10
Boston 9
Marano 9
Norwalk 9
Rio de Janeiro 9
Tokyo 9
Haiphong 8
Pune 8
Rome 8
Warsaw 8
Foggia 7
Johannesburg 7
Olomouc 7
Stockholm 7
Thái Bình 7
Xi'an 7
Council Bluffs 6
Da Nang 6
Gangbuk-gu 6
Hanover 6
Mexico City 6
Redwood City 6
Amsterdam 5
Campinas 5
Guayaquil 5
Hadfield 5
Helsinki 5
Jiaxing 5
Mumbai 5
Paris 5
Phoenix 5
Atlanta 4
Buenos Aires 4
Cosenza 4
Denver 4
Dongyang 4
Edmonton 4
Fortaleza 4
Guarulhos 4
Latina 4
Lima 4
Padova 4
Quito 4
Reggio Calabria 4
Ribeirão Preto 4
Salvador 4
Timisoara 4
Turin 4
Wuhan 4
Ann Arbor 3
Arco 3
Bangkok 3
Bari 3
Biên Hòa 3
Bogotá 3
Canoas 3
Charlotte 3
Clearwater 3
Cleveland 3
Totale 3.500
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 129
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 92
Comparative toxicity of diphenyl, diphenyl ether and some of their hydroxyderivatives 86
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 82
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 79
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 77
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 74
A novel phage display based platform for exosome diversity characterization 73
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 68
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 68
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 68
Crucial role for IBtk in the survival and maintenance of mature B cells 67
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 67
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 66
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 66
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 66
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 65
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 64
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 63
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 62
The aftermath of the Merck's HIV vaccine trial 62
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 62
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 62
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 62
Cancer-associated CD43 glycoforms as target of immunotherapy 62
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 61
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 60
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 57
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 57
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 57
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 55
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 54
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 53
Phage Display: An Overview in Context to Drug Discovery 53
Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein 53
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 52
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 51
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B 51
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 51
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 51
DNA damaging agents increase the stability of interleukin-1alfa, interleukin-1beta and interleukin-6 transcripts and the production of the relative proteins 50
Cancer-associated CD43 glycoforms as target of immunotherapy 50
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 50
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 50
A comparative study on the toxicity and mutagenicity of biphenyl (BP) and diphenyl ether (DPE) in sea urchin, S. typhimurium and S. cerevisiae. 49
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 49
A NF-kB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kB-activating stimuli 49
Autocrine growth function of interleukin-1 and interleukin-6 molecules on human transformed B cells 48
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 47
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 47
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 47
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 47
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 47
Mutagenicity of twelve imidazole derivatives with trichomonacide activity 46
I tests di mutagenesi nella valutazione della tossicologia dei farmaci. 46
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 46
Aspetti generali di tossicologia genetica 45
Crucial role for IBtkgamma in the survival and maintenance of matureB cells 45
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 44
Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein 44
Carcinogenic potency in rodents versus genotoxic potency in E. coli: a correlation analysis for bifunctional alkylating agents 43
High efficiency of site-directed mutagenesis mediated by a single PCR product 43
Metodo di attenuazione stabile di retrovirus HIV-1 e SIV per acquisizione di funzione: sviluppo di un virus vaccino attenuato per l'AIDS 43
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 43
Phage Display: An Overview in Context to Drug Discovery 43
Regulation of the HIV Promoter/Enhancer 42
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 42
Ultraviolet Mutagenesis 42
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 41
Expression of an exogenous interleukin-6 gene in human EBV-B cells confers growth advantage and in vivo tumorigenicity 41
Impaired generation of bone marrow B-lymphocytes in mice deficient in C/EBP beta 41
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 41
Polypeptide capable of inhibiting HIV-1 transcription and replication and uses thereof 41
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 41
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 41
Effect of DNOC, Ferbam and Imidan exposure on mouse sperm morphology 40
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors 40
Frameshift mutagenicity of furocoumarins in the dark 40
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 40
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 40
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 40
Spontaneous and mutagen-mediated amplification of a neo gene integrated at different genomic sites in Rat 2 fibroblasts 39
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 39
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 39
Insights into Thymus Development and Viral Thymic Infections 39
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 39
Screening of 24 pesticides by Salmonella/microsome assay: mutagenicity of benazolin, metoxuron and paraoxon. 38
Regulation of NF-kB through the nuclear processing of p105 (NF-kB1) in Epstein-Barr Virus- immortalized B cell lines 38
Genotoxicity and teratogenicity of diphenyl and diphenyl ether: a study of sea urchins, yeast, and Salmonella typhimurium 38
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 37
Sperm abnormalities in mice exposed to diesel particulate 37
Further validation of the E. coli multitest: in vitro and in vivo metabolic activation of procarcinogens 37
Multimodal Imaging for a Theranostic Approach in a Murine Model of B-cell Lymphoma with Engineered Nanoparticles 37
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 37
Mutagenic epoxide impurities discovered in two beta-adrenergic blocking agents 36
Perspectives for a Protective HIV-1 Vaccine in "HIV-1: Molecular Biology and Pathogenesis" 36
Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle 36
Monitoring of viremia and replicative status of Epstein Barr virus is useful for early diagnosis and modulation of therapy of lymphoproliferative disease in liver-transplant recipients. 36
Peptide-guided targeting of GPR55 for anti-cancer therapy. 36
Predictive value of Epstein-Barr virus genome copy number and BZLF1 expression in blood lymphocytes and transplant recipients at risk of lymphoproliferative disease 36
Totale 5.132
Categoria #
all - tutte 64.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 15 15 20 2 32 48 1 12
2021/2022466 9 9 7 111 27 10 21 130 29 50 60 3
2022/20231.182 272 35 63 67 128 95 7 114 228 68 80 25
2023/2024485 99 61 60 25 28 118 5 16 6 7 19 41
2024/20251.709 244 98 94 57 138 188 26 47 248 93 186 290
2025/20261.981 199 383 575 491 333 0 0 0 0 0 0 0
Totale 6.206